Inventaire - your friends and communities are your best library - Inventaire

Quality-of-life assessment in rheumatoid arthritis

published in: PharmacoEconomics

date of publication: 2008-01-01

main subject: quality of life, rheumatoid arthritis

Cites articles 68

Date

Title

Authors

2007-01-01

The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

Désirée van der Heijde, Josef S Smolen, Arthur Kavanaugh
2006-09-01

Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis
2006-03-01

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.

Paul Emery
2006-09-19

Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment

Paul Emery
2006-03-01

Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis
2006-12-29

Adaptation of the RAQoL for use in Australia

Nicola Massy-Westropp
2006-03-27

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial
2006-09-01

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

Paul Emery, Gerd-Rüdiger Burmester, Maxime Dougados, Stanley B Cohen
2006-10-01

Treating very early rheumatoid arthritis

Christopher D Buckley
2006-03-01

Community-based evaluation of etanercept in patients with rheumatoid arthritis
2006-03-01

Lack of efficacy of a third tumour necrosis factor alpha antagonist after failure of a soluble receptor and a monoclonal antibody

Sylvain Dubucquoi
2006-12-19

Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs
2006-02-01

Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis

Michael R Ehrenstein
2005-08-01

Quality of life and costs for different treatment strategies for rheumatoid arthritis
2005-08-01

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

Paul Emery, Maxime Dougados
2005-09-01

Quality of life in rheumatoid arthritis.

Till Uhlig, Tore K. Kvien
2005-01-01

An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists

Dean Regier, Alan Brennan, Nick Bansback
2005-08-03

Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial

Lars Klareskog
2005-03-01

What to do with TNF failures
2005-11-01

Touch-screen computer systems in the rheumatology clinic offer a reliable and user-friendly means of collecting quality-of-life and outcome data from patients with rheumatoid arthritis
2005-03-01

Estimating clinically significant differences in quality of life outcomes
2005-09-01

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition
2005-09-24

Adaptation of the rheumatoid arthritis quality of life scale for Estonia
2004-09-01

Cost-effectiveness of anti-tumor necrosis factor agents
2004-04-01

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

E. William St. Clair
2004-11-01

A comparison of four indirect methods of assessing utility values in rheumatoid arthritis
2004-03-23

Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate.

Peter Tugwell
2004-01-01

Patient-reported outcomes and their role in the assessment of rheumatoid arthritis
2003-05-01

The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab

Walter P Maksymowych
2003-04-01

OMERACT 6 brings new perspectives to rheumatology measurement research
2003-04-01

OMERACT 6 Economics Working Group report: a proposal for a reference case for economic evaluation in rheumatoid arthritis

Peter Tugwell, Doug Coyle, Vivian Welch, Andreas Maetzel
2003-07-01

Variation in the estimation of quality-adjusted life-years by different preference-based instruments.

Article - wd:Q37269344

Welcome to Inventaire

the library of your friends and communities

you are offline